GlassScriptPhysician profile
Carissa Gralewski
NPI 1770314981
$608.03
in general payments reported to CMS, 2019-2025
18 companies · $608 in 2025
The $608 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $150.05 | 2025 | |
| Exact Sciences Corporation | $72.65 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $44.65 | 2025 | Auvelity |
| Bausch Health US, LLC | $41.12 | 2025 | Aplenzin |
| Astrazeneca Pharmaceuticals LP | $36.47 | 2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $29.34 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.78 | 2025 | Xifaxan |
| Ucb, INC. | $26.58 | 2025 | Rystiggo |
| Corium, LLC | $26.01 | 2025 | Azstarys |
| Sumitomo Pharma America, INC. | $20.57 | 2025 | Gemtesa |
| Pfizer INC. | $18.80 | 2025 | |
| Noven Therapeutics, LLC | $18.34 | 2025 | Xelstrym |
| Glaxosmithkline, LLC. | $18.08 | 2025 | Trelegy Ellipta |
| Genentech USA, INC. | $16.86 | 2025 | Ocrevus Zunovo |
| Novo Nordisk INC | $16.65 | 2025 | Ozempic, Rybelsus |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $16.14 | 2025 | Relexxii |
| Lilly USA, LLC | $14.06 | 2025 | Zepbound |
| Collegium Pharmaceutical, INC. | $13.88 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Gralewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.